New tablet shows promise for chronic hives in small study
NCT ID NCT07611032
First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times
Summary
This study tested a daily tablet called NatureU Histra Disslove in 19 adults with chronic hives. Participants took one tablet before a main meal for 28 days. The study measured how well the tablet controlled hives, reduced symptoms, and improved quality of life. Results showed changes in hive control and activity scores from the start to the end of the study.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANGIOEDEMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Dao County People's Hospital
Yongzhou, Hunan, 425300, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Ancient herb mix put to the test against stubborn hives
- Could a histamine shot tame chronic hives?
- Can a smartphone app ease the misery of eczema, psoriasis, and hives?
- AI tool aims to cut allergy misdiagnosis in primary care
- New gel promises Ultra-Fast itch relief in seconds
- Ear seeds and allergy pills: a new combo for hives?